Google

Thursday, May 3, 2007

Review: Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure

Review: Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure

In this article, the authors review the significant findings related to the use of thiazolidinediones (TZDs) in the treatment of patients with type 2 diabetes mellitus and heart failure. They cover the following areas:

  • Benefits of TZDs on cardiovascular surrogate endpoints
  • Weight gain
  • Oedema
  • Heart failure
  • Observational studies
  • Prospective clinical trial (PROactive)
The authors note that ‘because of the potential for fluid retention and worsening oedema, clinical studies have excluded patients with New York Heart Association (NYHA) functional class III or IV heart failure. In patients at risk for heart failure or those who have NYHA functional class I or II symptoms, initiation of therapy should be at the lower dose for TZDs with close monitoring of weight gain, oedema, and other signs of worsening heart failure … patients with NYHA functional class III or IV heart failure should not receive TZDs’.

Am J Health Syst Pharm 2007; 64: 931-6 (link to abstract)

1 comment:

buy tadalista 20 mg online said...

tadalista 20 mg is used to treat erection problems and symptoms of an enlarged prostate. It's also sometimes used to treat pulmonary hypertension high blood pressure in the blood vessels that supply the lungs.